Strategy Inc logo MSTR - Strategy Inc

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 8
SELL 3
STRONG
SELL
0
| PRICE TARGET: $214.17 DETAILS
HIGH: $350.00
LOW: $130.00
MEDIAN: $212.50
CONSENSUS: $214.17
UPSIDE: 126.30%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Distressed or Transitioning 75% confidence

Primary model: Current EPS × Depressed Multiple

Valuation Signal Overvalued Strong
Trading 69.3% above fair value
Current Price $94.64
Bear Case $37.16 60.7% downside ($37.16 - $94.64) / $94.64 = -60.7% EPS continues to decline, 5x multiple
Fair Value $55.91 40.9% downside ($55.91 - $94.64) / $94.64 = -40.9% Current EPS stabilizes, 8x multiple
Bull Case $74.49 21.3% downside ($74.49 - $94.64) / $94.64 = -21.3% Credible recovery, multiple re-rates to 10x

Adjust Assumptions

7.5x

Key Value Driver

Whether the core business model is intact or structurally impaired

Implied Market Multiple 224.8x

Plain-Language Summary

Our base-case estimate uses Current EPS × Depressed Multiple. We then blend that result with the average analyst price target of $214.17 from 29 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $55.91 per share.

Warnings

Don't assume past cash flow levels will return — the company's troubles may have permanently reduced its ability to generate profits.
A stock can look cheap on paper and still lose half its value if the underlying business is permanently damaged.
The wide range between our best and worst cases is intentional — pretending to know a precise value for a troubled company would be misleading.
Wall Street's average price target is $214.17 (from 29 analysts). Our estimate is 99% below the consensus -- consider that gap carefully.

Key Risks

  • Bullish DCF projections are fundamentally unknowable for distressed companies
  • M&A speculation can floor the stock above intrinsic value temporarily
  • Management credibility is a key input — new CEO expands the bull case